Paramount Cosmet

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE143I01013
  • NSEID:
  • BSEID: 507970
INR
35.51
0.37 (1.05%)
BSENSE

May 20

BSE+NSE Vol: 131

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

131 (-88.78%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.03%

Held by 0 DIIs

Promoter

74.78%

Who are in the management team of Paramount Cosmet?

06-Jun-2025

As of March 2022, the management team of Paramount Cosmet includes Hitesh Topiwaala (Managing Director), V N Mehta (Non-Executive & Independent Director), Aarti Topiwala (Non-Executive & Non-Independent Director), and Reshma M (Company Secretary & Compliance Officer). Hitesh Topiwaala receives a remuneration of Rs. 83.0 lacs, while the others do not receive any remuneration.

As of March 2022, the management team of Paramount Cosmet includes the following individuals:<BR><BR>1. Hitesh Topiwaala - Managing Director, with a remuneration of Rs. 83.0 lacs.<BR>2. V N Mehta - Non-Executive & Independent Director, with no remuneration.<BR>3. Aarti Topiwala - Non-Executive & Non-Independent Director, with no remuneration.<BR>4. Reshma M - Company Secretary & Compliance Officer, with no remuneration. <BR><BR>This team plays a crucial role in the governance and operational oversight of the company.

View full answer

Has Paramount Cosmet declared dividend?

06-Jun-2025

Yes, Paramount Cosmetics (India) Ltd declared a 5% dividend (0.5 per share) on September 21, 2017, but the current dividend yield is 0%. Total returns over various periods show mixed performance, with significant gains over longer durations despite some negative returns in shorter time frames.

Yes, Paramount Cosmetics (India) Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 21 Sep 17<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -26.04%, the dividend return was 0%, resulting in a total return of -26.04%.<BR><BR>In the 1-year period, the price return was 3.54%, the dividend return was 0%, resulting in a total return of 3.54%.<BR><BR>In the 2-year period, the price return was 8.89%, the dividend return was 0%, resulting in a total return of 8.89%.<BR><BR>In the 3-year period, the price return was -27.07%, the dividend return was 0%, resulting in a total return of -27.07%.<BR><BR>In the 4-year period, the price return was 106.32%, the dividend return was 0%, resulting in a total return of 106.32%.<BR><BR>In the 5-year period, the price return was 241.76%, the dividend return was 0%, resulting in a total return of 241.76%.<BR><BR>Overall, while Paramount Cosmetics declared a dividend in the past, the current dividend yield stands at 0%. The total returns over various periods show a mix of performance, with significant gains over longer periods despite some negative returns in shorter time frames.

View full answer

What is the technical trend for Paramount Cosmet?

09-Jun-2025

As of June 6, 2025, Paramount Cosmet's technical trend is mildly bearish, indicated by bearish weekly moving averages and MACD, despite a mildly bullish KST on the weekly chart.

As of 6 June 2025, the technical trend for Paramount Cosmet has changed from bearish to mildly bearish. The weekly MACD remains bearish, while the monthly MACD shows a mildly bearish stance. Both the weekly and monthly Bollinger Bands indicate a mildly bearish trend. Daily moving averages are bearish, suggesting short-term weakness. The KST shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly. Dow Theory indicates a mildly bullish trend on the weekly but no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the bearish MACD on the weekly timeframe.

View full answer

Who are the peers of the Paramount Cosmet?

16-Jul-2025

Paramount Cosmet's peers include Hipolin, Sinnar Bidi Udy., KMG Milk Food, Novateor Research, Tasty Dairy, BKV Industries, Octavius Plant, and Shanthala FMCG. Most peers exhibit below average management risk and growth, with KMG Milk Food showing the highest 1-year return at 44.01%, while Paramount Cosmet's return is -1.87%.

Peers: The peers of Paramount Cosmet are Hipolin, Sinnar Bidi Udy., KMG Milk Food, Novateor Resear., Tasty Dairy, BKV Industries, Octavius Plant., and Shanthala FMCG.<BR><BR>Quality Snapshot: Below Average management risk is observed at Hipolin, Sinnar Bidi Udy., Novateor Resear., Tasty Dairy, Paramount Cosmet, and Shanthala FMCG, while Average management risk is found at Octavius Plant. KMG Milk Food and BKV Industries do not qualify for management risk assessment. For growth, Below Average ratings are noted for Hipolin, Sinnar Bidi Udy., Novateor Resear., Paramount Cosmet, and Shanthala FMCG, while Average growth is seen at Tasty Dairy. KMG Milk Food and BKV Industries do not qualify for growth assessment. In terms of capital structure, Below Average ratings are given to Hipolin, Sinnar Bidi Udy., Novateor Resear., Tasty Dairy, Paramount Cosmet, and Shanthala FMCG, while Average capital structure is noted for Octavius Plant. KMG Milk Food and BKV Industries do not qualify for capital structure assessment.<BR><BR>Return Snapshot: The peer with the highest 1-year return is KMG Milk Food at 44.01%, while the lowest is Shanthala FMCG at 0.00%. Paramount Cosmet's 1-year return is -1.87%, which is lower than KMG Milk Food's but higher than Shanthala FMCG's. Additionally, the six-month returns for Hipolin, Tasty Dairy, Octavius Plant., and Shanthala FMCG are negative.

View full answer

What does Paramount Cosmet do?

17-Jul-2025

Paramount Cosmetics (India) Ltd is a micro-cap FMCG company that manufactures and markets cosmetic products. As of March 2025, it reported net sales of 60 Cr and a net profit of 0 Cr, with a market cap of INR 21 Cr.

Overview: <BR>Paramount Cosmetics (India) Ltd is a micro-cap company in the FMCG industry that manufactures and markets indigenous and western cosmetic products.<BR><BR>History: <BR>The company was incorporated in November 1985 and was formerly known as Tips & Toes Cosmetics Ltd. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 60 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap: INR 21 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.52 <BR>Return on Equity: 0.10% <BR>Price to Book: 1.01 <BR><BR>Contact Details: <BR>Address: A-1 2211 3rd Phase, GIDC Vapi Valsad Gujarat : 396195 <BR>Tel: 91-80-2532 0870/71 <BR>Email: compliance.officer@parammount.com <BR>Website: http://www.parammount.com

View full answer

Who are the top shareholders of the Paramount Cosmet?

17-Jul-2025

The top shareholder of Paramount Cosmet is Hiitesh Topiiwaalla, who holds 52.79% of the shares. There are no pledged promoter holdings, and individual investors own 20.19% of the shares, with no mutual funds or foreign institutional investors currently involved.

The top shareholders of Paramount Cosmet are primarily the promoters, with Hiitesh Topiiwaalla holding the largest share at 52.79%. There are no pledged promoter holdings, and currently, there are no mutual funds or foreign institutional investors (FIIs) holding shares in the company. Additionally, individual investors collectively hold 20.19% of the shares.

View full answer

How big is Paramount Cosmet?

24-Jul-2025

As of 24th July, Paramount Cosmetics (India) Ltd has a market capitalization of 20.00 Cr, with recent net sales of 20.39 Cr and a net profit of 0.02 Cr. Shareholder's funds are 20.31 Cr, and total assets are 40.41 Cr.

As of 24th July, Paramount Cosmetics (India) Ltd has a market capitalization of 20.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 20.39 Cr and a Net Profit of 0.02 Cr.<BR><BR>For the latest annual period ending March 2024, Shareholder's Funds were recorded at 20.31 Cr, while Total Assets amounted to 40.41 Cr.

View full answer

How has been the historical performance of Paramount Cosmet?

24-Nov-2025

Paramount Cosmet has experienced declining financial performance, with net sales dropping from 26.72 Cr in March 2023 to 20.38 Cr in March 2025, and profit after tax decreasing from 0.34 Cr in March 2021 to 0.03 Cr in March 2025, despite a reduction in total liabilities and assets. Operating profit has also shown volatility, falling to 0.98 Cr in March 2025.

Answer:<BR>The historical performance of Paramount Cosmet shows fluctuations in key financial metrics over the years, particularly in net sales, operating profit, and profit after tax.<BR><BR>Breakdown:<BR>Paramount Cosmet's net sales peaked at 26.72 Cr in March 2023 but have since declined to 20.38 Cr by March 2025. The total operating income followed a similar trend, decreasing from 26.72 Cr in March 2023 to 20.38 Cr in March 2025. The company experienced a significant reduction in raw material costs, which dropped to zero in March 2025 from 5.80 Cr in March 2023. However, the purchase of finished goods surged to 17.33 Cr in March 2025, contributing to total expenditure of 19.40 Cr for the same period. Operating profit (PBDIT) has shown volatility, with a high of 3.96 Cr in March 2020, but falling to 0.98 Cr in March 2025. Profit before tax and profit after tax also reflected this downward trend, with profit after tax declining to 0.03 Cr in March 2025 from a high of 0.34 Cr in March 2021. The company's total liabilities decreased from 48.75 Cr in March 2020 to 40.04 Cr in March 2025, while total assets also fell from 48.75 Cr to 40.04 Cr over the same period. Cash flow from operating activities remained stagnant, with no net cash inflow or outflow reported in recent years. Overall, Paramount Cosmet's financial performance has been characterized by declining sales and profits, alongside a reduction in liabilities and assets.

View full answer

Is Paramount Cosmet overvalued or undervalued?

03-Dec-2025

As of December 2, 2025, Paramount Cosmet's valuation has improved to very attractive, indicating it is undervalued compared to peers like Hindustan Unilever and Nestle India, with a high PE ratio of 303.92, yet it has recently outperformed the Sensex with a 1-week return of 4.33%.

As of 2 December 2025, the valuation grade for Paramount Cosmet has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Notable headline ratios include a PE Ratio of 303.92, an EV to EBITDA of 22.09, and a Price to Book Value of 0.89, which suggests that the stock may be mispriced relative to its intrinsic value.<BR><BR>In comparison to peers, Hindustan Unilever has a PE Ratio of 55.03 and an EV to EBITDA of 39.00, while Nestle India shows a PE of 81.19 and an EV to EBITDA of 50.36, both of which are significantly lower than Paramount's ratios. This highlights that Paramount Cosmet may offer a more attractive investment opportunity despite its high PE ratio. Additionally, while the company's recent stock performance has lagged behind the Sensex over the past year, it has outperformed in the short term, with a 1-week return of 4.33% compared to the Sensex's 0.65%.

View full answer

When is the next results date for Paramount Cosmetics (India) Ltd?

05-May-2026

The next results date for Paramount Cosmetics (India) Ltd is 08 May 2026.

The next results date for Paramount Cosmetics (India) Ltd is scheduled for 08 May 2026.

View full answer

Are Paramount Cosmetics (India) Ltd latest results good or bad?

09-May-2026

The latest results for Paramount Cosmetics (India) Ltd are concerning, showing a 53.34% year-on-year decline in net sales to ₹2.79 crores and a net loss of ₹0.05 crores, indicating significant operational challenges and financial instability.

The latest results for Paramount Cosmetics (India) Ltd are concerning and indicate a significant deterioration in financial performance. In the quarter ending March 2026, the company reported net sales of ₹2.79 crores, which represents a staggering decline of 53.34% year-on-year and a 46.65% drop from the previous quarter. This marks the lowest quarterly revenue recorded in the available data.<BR><BR>Additionally, the company incurred a net loss of ₹0.05 crores, a reversal from a profit of ₹0.03 crores in the prior quarter. The interest coverage ratio is critically low at 0.08 times, meaning the company's operating profits are insufficient to cover its interest obligations, raising serious concerns about its financial sustainability.<BR><BR>While there was an improvement in operating margins, which rose to 16.49% from 4.02% in the previous quarter, this increase is largely overshadowed by the severe revenue decline. The overall financial picture suggests that Paramount Cosmetics is facing significant operational challenges, making the latest results decidedly negative.

View full answer

Should I buy, sell or hold Paramount Cosmetics (India) Ltd?

12-May-2026

Why is Paramount Cosmetics (India) Ltd falling/rising?

20-May-2026

As of 19-May, Paramount Cosmetics (India) Ltd's stock is declining, currently priced at 35.14, reflecting a 4.69% drop. Despite increased investor participation, the stock shows a longer-term downward trend and is underperforming against the benchmark Sensex.

As of 19-May, Paramount Cosmetics (India) Ltd's stock price is falling, currently at 35.14, which reflects a decrease of 1.73 or 4.69%. This decline is evident in the stock's performance over various periods, showing a 4.98% drop over the past week and a 7.53% decrease over the past month. Additionally, the stock has underperformed against the benchmark Sensex, which has gained 0.86% in the last week.<BR><BR>Today's performance indicates a trend reversal, as the stock has fallen after three consecutive days of gains. Although the stock's moving averages are higher than the 5-day, 20-day, 50-day, and 100-day averages, they remain lower than the 200-day moving average, suggesting a longer-term downward trend. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 113.71% against the 5-day average, the overall sentiment appears negative, contributing to the stock's decline. The stock's liquidity is adequate for trading, but the combination of recent performance metrics and the trend reversal indicates that the stock is currently facing downward pressure.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -7.13% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.20
  • The company has been able to generate a Return on Equity (avg) of 0.52% signifying low profitability per unit of shareholders funds
2

Flat results in Mar 26

3

With ROE of 0.2, it has a Expensive valuation with a 0.8 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 17 Cr (Micro Cap)

stock-summary
P/E

345.00

stock-summary
Industry P/E

47

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

0.24%

stock-summary
Price to Book

0.87

Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.34%
0%
-0.34%
6 Months
-5.31%
0%
-5.31%
1 Year
-11.23%
0%
-11.23%
2 Years
-13.39%
0%
-13.39%
3 Years
-1.33%
0%
-1.33%
4 Years
-52.37%
0%
-52.37%
5 Years
81.17%
0%
81.17%

Latest dividend: 0.5 per share ex-dividend date: Sep-21-2017

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Paramount Cosmetics Falls 1.15%: Valuation Concerns and Flat Financials Weigh

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-May-2026 | Source : BSE

Submission of Newspaper Publication.

Non Applicability Of Statement Of Deviation & Variation

09-May-2026 | Source : BSE

Submission of Non Applicability of Statement of Deviation & Variation

Financial Results For The Year And Quarter Ended On 31.03.2026

08-May-2026 | Source : BSE

Please find attached Financial Results for the Year and Quarter Ended on 31.03.2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Paramount Cosmetics (India) Ltd has declared 5% dividend, ex-date: 21 Sep 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.08%
EBIT Growth (5y)
-7.13%
EBIT to Interest (avg)
0.20
Debt to EBITDA (avg)
7.43
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
0.71
Tax Ratio
79.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
3.61%
ROE (avg)
0.52%

Valuation key factors

Factor
Value
P/E Ratio
345
Industry P/E
47
Price to Book Value
0.84
EV to EBIT
17.27
EV to EBITDA
11.93
EV to Capital Employed
0.85
EV to Sales
0.85
PEG Ratio
2.30
Dividend Yield
NA
ROCE (Latest)
4.91%
ROE (Latest)
0.24%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Hiitesh Topiiwaalla (52.79%)

Highest Public shareholder

None

Individual Investors Holdings

20.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -46.65% vs -39.82% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -266.67% vs -76.92% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.79",
          "val2": "5.23",
          "chgp": "-46.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.46",
          "val2": "0.21",
          "chgp": "119.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.59",
          "val2": "0.28",
          "chgp": "110.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.05",
          "val2": "0.03",
          "chgp": "-266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.49%",
          "val2": "4.02%",
          "chgp": "12.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 51.07% vs -15.15% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 133.33% vs -85.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.37",
          "val2": "8.85",
          "chgp": "51.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.85",
          "val2": "0.61",
          "chgp": "39.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.96",
          "val2": "0.85",
          "chgp": "12.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.07",
          "val2": "0.03",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.36%",
          "val2": "6.89%",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 29.08% vs -13.76% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 100.00% vs -78.26% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.60",
          "val2": "14.41",
          "chgp": "29.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.06",
          "val2": "0.95",
          "chgp": "11.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.24",
          "val2": "1.26",
          "chgp": "-1.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.10",
          "val2": "0.05",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.70%",
          "val2": "6.59%",
          "chgp": "-0.89%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.96% vs -6.56% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 66.67% vs 50.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.39",
          "val2": "20.38",
          "chgp": "4.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.51",
          "val2": "0.98",
          "chgp": "54.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.83",
          "val2": "1.60",
          "chgp": "14.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.05",
          "val2": "0.03",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.06%",
          "val2": "4.81%",
          "chgp": "2.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
2.79
5.23
-46.65%
Operating Profit (PBDIT) excl Other Income
0.46
0.21
119.05%
Interest
0.59
0.28
110.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.05
0.03
-266.67%
Operating Profit Margin (Excl OI)
16.49%
4.02%
12.47%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -46.65% vs -39.82% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -266.67% vs -76.92% in Dec 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
13.37
8.85
51.07%
Operating Profit (PBDIT) excl Other Income
0.85
0.61
39.34%
Interest
0.96
0.85
12.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.07
0.03
133.33%
Operating Profit Margin (Excl OI)
6.36%
6.89%
-0.53%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 51.07% vs -15.15% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 133.33% vs -85.00% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
18.60
14.41
29.08%
Operating Profit (PBDIT) excl Other Income
1.06
0.95
11.58%
Interest
1.24
1.26
-1.59%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.10
0.05
100.00%
Operating Profit Margin (Excl OI)
5.70%
6.59%
-0.89%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 29.08% vs -13.76% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 100.00% vs -78.26% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
21.39
20.38
4.96%
Operating Profit (PBDIT) excl Other Income
1.51
0.98
54.08%
Interest
1.83
1.60
14.37%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.05
0.03
66.67%
Operating Profit Margin (Excl OI)
7.06%
4.81%
2.25%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 4.96% vs -6.56% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 66.67% vs 50.00% in Mar 2025

stock-summaryCompany CV
About Paramount Cosmetics (India) Ltd stock-summary
stock-summary
Paramount Cosmetics (India) Ltd
Micro Cap
FMCG
Paramount Cosmetics (India) Ltd (formerly known Tips & Toes Cosmetics Ltd) was incorporated in November 1985. The company manufactures and markets indigenous and western cosmetics products under the brand names Tips & Toes, Shilpa, and Shingar. It markets a western range of cosmetic products like Tips & Toes nail lustre, lip lustre, cream, blush-on, compact powder, talcum powder, eye definer, sindoor, etc.
Company Coordinates stock-summary
Company Details
A-1 2211 3rd Phase, GIDC Vapi Valsad Gujarat : 396195
stock-summary
Tel: 91-80-2532 0870/71
stock-summary
compliance.officer@parammount.com
Registrar Details
BgSE Financials Ltd, No.51, Stock Exchange Towers, 1st Cross, J.C.Road, Bangalore